Open

Study for People with Idiopathic Pulmonary Fibrosis (IPF)

We are looking for volunteers to try an oral medication called Ifetroban. We are doing a study to see if taking an Ifetroban pill helps people with Idiopathic Pulmonary Fibrosis. We will also make sure the medicine is safe and easy for people to take. This study will help us learn if it can improve the health of people with this lung disease. Adults with IPF are welcome to participate.

Age & Gender

40 years ~ 99 years
Male, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

Join us for in-person visits where we will: - Check your blood pressure, heart rate, and other important health signs - Take a small blood sample - Have a doctor examine you - Answer a few questions on a form - Get more of the study medication to take home Some visits will also have: - Breathing tests - Special X-ray scans (2 times total) We will also call you for short phone visits where we will: - Ask about your medications - Talk about how the study medication is working for you

Incentives

Get free study medication and regular check-ups.

In-person visits:
7

Phone or online visits:
5

Total length of participation:
Up to 1 year

Looking for Specific Volunteers

Able to participate:

Are age 40 or older
Have a diagnosis of Idiopathic Pulmonary Fibrosis (IPF)

Not eligible if:

Have cardiovascular (heart) disease
Have a history of cancer (treated or untreated) in the last 5 years except for skin cancer
You have Pulmonary Arterial Hypertension (PAH)
You are pregnant, nursing, or plan to become pregnant while in the trial.
You've had a stroke or heart attack in the last year

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Clinical Research Unit
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Brent Kinder
Medicine-Pulmonary

Study Type

Clinical or Medical
Interventional

Study Topics

Chronic Conditions
Lungs and Breathing

IRB Number

25-1280

ClinicalTrials.gov

NCT05571059

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.